Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells

• Published in: International journal of molecular sciences Vol. 25; no. 4; p. 2284
• Main Authors: Jramne-Saleem, Yasmeen, Danilenko, Michael
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.02.2024
• Subjects: Abietanes; activator protein-1; acute myeloid leukemia; Antioxidants; Antioxidants - pharmacology; buthionine sulfoximine; Cancer; carnosic acid; Cell Differentiation; Chemotherapy; Drug therapy, Combination; Epigenetic inheritance; Glutathione - metabolism; Humans; Leukemia; Leukemia, Myeloid, Acute - drug therapy; Leukemia, Myeloid, Acute - metabolism; Ligands; monomethyl fumarate; NF-E2-Related Factor 2 - metabolism; Older people; Paricalcitol; Patients; Polyphenols; Protein expression; Proteins; Receptors, Calcitriol - metabolism; Signal Transduction; Thiols; Toxicity; Transcription Factor AP-1 - metabolism; Transcription factors; Vitamin D; Vitamin D - therapeutic use; vitamin D receptor; Vitamins - pharmacology; Israel; vitamin D receptor; acute myeloid leukemia; buthionine sulfoximine; activator protein-1; carnosic acid; monomethyl fumarate
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25042284

Active vitamin D derivatives (VDDs)-1α,25-dihydroxyvitamin D /D and their synthetic analogs-are well-known inducers of cell maturation with the potential for differentiation therapy of acute myeloid leukemia (AML). However, their dose-limiting calcemic activity is a significant obstacle to using VDDs as an anticancer treatment. We have shown that different activators of the NF-E2-related factor-2/Antioxidant Response Element (Nrf2/ARE) signaling pathway, such as the phenolic antioxidant carnosic acid (CA) or the multiple sclerosis drug monomethyl fumarate (MMF), synergistically enhance the antileukemic effects of various VDDs applied at low concentrations in vitro and in vivo. This study aimed to investigate whether glutathione, the major cellular antioxidant and the product of the Nrf2/ARE pathway, can mediate the Nrf2-dependent differentiation-enhancing activity of CA and MMF in HL60 human AML cells. We report that glutathione depletion using L-buthionine sulfoximine attenuated the enhancing effects of both Nrf2 activators concomitant with downregulating vitamin D receptor (VDR) target genes and the activator protein-1 (AP-1) family protein c-Jun levels and phosphorylation. On the other hand, adding reduced glutathione ethyl ester to dominant negative Nrf2-expressing cells restored both the suppressed differentiation responses and the downregulated expression of VDR protein, VDR target genes, as well as c-Jun and P-c-Jun levels. Finally, using the transcription factor decoy strategy, we demonstrated that AP-1 is necessary for the enhancement by CA and MMF of 1α,25-dihydroxyvitamin D -induced VDR and RXRα protein expression, transactivation of the vitamin D response element, and cell differentiation. Collectively, our findings suggest that glutathione mediates, at least in part, the potentiating effect of Nrf2 activators on VDDs-induced differentiation of AML cells, likely through the positive regulation of AP-1.